Emgality 120 mg/mL single-dose prefilled pen Images
Generic Name: galcanezumab
This medication has been identified as Emgality 120 mg/mL single-dose prefilled pen. It is supplied by Eli Lilly and Company.
Emgality is used in the treatment of Cluster Headaches; Migraine Prevention and belongs to the drug class CGRP inhibitors. Emgality 120 mg/mL single-dose prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication


Emgality
- Generic Name
- galcanezumab
- Strength
- 120 mg/mL single-dose prefilled pen
- Availability
- Prescription only
- Drug Class
- CGRP inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-1436
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Qulipta
Qulipta is used to help prevent episodic or chronic migraine headaches in adults. Qulipta is an ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Imitrex
Imitrex (sumatriptan) is used to treat migraine headaches, with or without aura, in adults ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
More about Emgality (galcanezumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (499)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.